Skip to main content
. 2016 May 30;7(28):43868–43893. doi: 10.18632/oncotarget.9701

Table 6. Proteins which show statistically differential expression between good outcome and distant recurrence of Stage IIIB and IIIC CRC patients.

Accession Description p-value Relative Abundance
Mean of G1-G4 Mean of P1-P4
P17661 Desmin GN=DES 5.51E-05 0.991 0.412
Q14315 Filamin-C GN=FLNC 7.37E-05 0.966 0.657
P09417 Dihydropteridine reductase GN=QDPR 2.16E-04 0.955 0.650
P35749 Myosin-11 GN=MYH11 5.80E-04 1.027 0.548
P07951 Tropomyosin beta chain GN=TPM2 6.90E-04 1.006 0.668
P24844 Myosin regulatory light polypeptide 9 GN=MYL9 7.72E-04 1.052 0.672
P62736 Actin, aortic smooth muscle GN=ACTA2 9.25E-04 1.012 0.679
Q9UPN4 Centrosomal protein of 131 kDa GN=CEP131 1.98E-03 1.071 0.478
Q01995 Transgelin GN=TAGLN 8.53E-03 1.094 0.664
Q15005 Signal peptidase complex subunit 2 GN=SPCS2 1.49E-02 0.972 0.624
Q9UNH7 Sorting nexin-6 GN=SNX6 1.85E-02 0.969 1.687
O15061 Synemin GN=SYNM 1.86E-02 1.136 0.636
P10301 Ras-related protein R-Ras GN=RRAS 2.50E-02 0.994 0.626
Q96DG6 Carboxymethylenebutenolidase homolog GN=CMBL 2.79E-02 1.016 0.657
Q9C075 Keratin, type I cytoskeletal 23 GN=KRT23 3.28E-02 0.981 2.145
Q9HCY8 Protein S100-A14 GN=S100A14 3.96E-02 0.918 0.612
Q6WKZ4 Rab11 family-interacting protein 1 GN=RAB11FIP1 4.01E-02 0.979 1.636
P11387 DNA topoisomerase 1 GN=TOP1 4.91E-02 0.918 1.339